2024-10-25 - Analysis Report
## Cigna Group (CI) Stock Analysis

### 1. Performance Comparison with S&P 500

**Cigna Group (CI)** is a health insurance and health services company providing insurance and related products and services to individuals, employers and other customers.

* **Cumulative Return:** 132.85%
* **S&P 500 (VOO) Cumulative Return:** 135.48%
* **Performance Gap:** -2.63%
* **Relative Performance:** 30.92% (This means CI's performance is currently in the 30.92th percentile compared to its historical performance relative to the S&P 500)

### 2. Recent Price Movement

* **Closing Price:** $318.24 (Post-market: $318.25)
* **5-day Moving Average:** $322.44
* **20-day Moving Average:** $341.10
* **60-day Moving Average:** $346.20

The price is currently below all three moving averages, suggesting a potential downward trend.

### 3. Technical Indicators

* **RSI:** 32.4 (Indicates oversold conditions)
* **PPO:** -1.03 (Indicates potential for a downward trend)
* **Delta_Previous_Relative_Divergence:** -15.01 (Short-term bearish trend)
* **Expected Return:** 0.0% (Over a long-term investment horizon of 2+ years, the expected return relative to the S&P 500 is neutral)

### 4. Recent Earnings and Outlook

| Date | EPS | Revenue |
|---|---|---|
| 2024-08-01 | 5.51 | $60.52B |
| 2024-05-02 | -0.97 | $57.26B |
| 2023-11-02 | 4.79 | $49.05B |
| 2023-08-03 | 4.96 | $48.59B |
| 2024-08-01 | 4.96 | $48.59B |

The most recent earnings report for Q2 2024 showed EPS of $5.51, beating analyst estimates by $0.13. Revenue also exceeded expectations, coming in at $60.52 billion compared to the anticipated $59.93 billion. Cigna's earnings were driven by strong growth in its health insurance segment and its pharmacy benefit management business.

However, the company's guidance for the remainder of 2024 indicates a slower growth trajectory, with the management team citing concerns over rising healthcare costs and competitive pressures.

### 5. News and Recent Issues

* **Recent Earnings Call Transcript:** The latest earnings call transcript highlighted Cigna's focus on cost-containment measures, expanding its Medicare Advantage offerings, and driving digital transformation initiatives.
* **Analyst Opinions:** Analysts currently hold a "Hold" consensus rating for Cigna, with a price target of $330.00. Many analysts are cautiously optimistic about the company's long-term prospects, recognizing the potential for growth in the health insurance market but expressing concerns about the near-term outlook due to economic uncertainty and rising healthcare costs. 

### 6. Overall Analysis

Cigna Group (CI) currently exhibits a neutral performance compared to the S&P 500. The stock is experiencing some downward pressure based on recent price action and technical indicators, although it is currently oversold. Cigna's recent earnings beat analyst expectations, but its outlook suggests a slower growth path in the near future. 

**Overall, Cigna is a strong company with a solid position in the healthcare market, but its future prospects are somewhat uncertain due to macroeconomic and industry-specific headwinds. Investors should monitor Cigna's performance closely and consider its long-term growth potential before making an investment decision.**

### 7. Disclaimer:

This analysis is based on publicly available information and is not financial advice. It is not a recommendation to buy or sell any security and investors should conduct their own research before making any investment decisions. 
